CIK 0001020214
- Accelerated filer
CERUS CORP
Sign in to watch- Ticker
- CERS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680262011
- Phone
- +1 925-288-6000
- Business address
- 1220 CONCORD AVENUE, SUITE 600, CONCORD, CA, 94520
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Chief Med & Scientific Officer acquired 25,000 shares (option exercise)
- 4 Exercise or conversion Chief Med & Scientific Officer acquired 50,000 shares (option exercise)
- 4 Exercise or conversion Chief Med & Scientific Officer acquired 50,000 shares (option exercise)
- 4 Exercise or conversion President and CEO acquired 46,500 shares (option exercise)
- 4 Exercise or conversion Chief Med & Scientific Officer acquired 34,000 shares (option exercise)
- 4 Open-market sale Director sold 556 shares at $4.92 ($2,736)
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion Director acquired 24,375 shares (option exercise)
- 4 Exercise or conversion Director acquired 3,333 shares (option exercise)
- 4 Exercise or conversion President and CEO acquired 50 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Exercise or conversion President and CEO acquired 53,500 shares (option exercise)
- 4 Exercise or conversion President and CEO acquired 53,500 shares (option exercise)
- 4 Exercise or conversion Director acquired 3,334 shares (option exercise)
- 4 Exercise or conversion Chief Med & Scientific Officer acquired 1,000 shares (option exercise)
Page 22 of 36 · 701 filings